Help us defend bioidentical hormone replacement therapy from an FDA ban. Action Alert! We at ANH-USA have been keeping a close watch over the FDA’s ongoing process to regulate customized, natural medicines made at compounding pharmacies. Time and time again throughout this process, we’ve seen the FDA ban safe, natural ingredients from being used in… Continue reading Hormones: The Fight Continues
Category: Health Autonomy
HSA Upgrade
Help us fight for expanded Health Savings accounts. Action Alert! For many years, ANH-USA has supported efforts that would allow Health Savings Account (HSA) and Flexible Saving Account (FSA) funds to pay for dietary supplements. Federal bills including this reform have been introduced in 2011, 2013, 2017, and 2019, but have not yet passed. Congressman… Continue reading HSA Upgrade
More Local Control Over 5G
New legislation will help communities control how 5G gets implemented. Action Alert! New bills in the House and Senate will roll back FCC regulations that prevent local communities from having input over how 5G networks get installed in their towns. We must encourage our elected officials to support this legislation, and more importantly, urge them… Continue reading More Local Control Over 5G
Will the FDA Close Your Pharmacy?
It may come to that if a key policy isn’t changed. Action Alert! As part of its effort to implement the Drug Quality and Security Act of 2013, the FDA issued a revision of a bad policy that will limit the amount of medicines compounding pharmacies can send out of state. The revision offers some… Continue reading Will the FDA Close Your Pharmacy?
FDA Allows Carcinogens In Popular Drugs
More evidence that the drug approval process is completely broken. A pharmacy recently alerted the FDA to the presence of a cancer-causing chemical in the popular blood-pressure drug valsartan, putting millions of patients at risk. Incredibly, this isn’t even the first time dangerous chemicals have been found in this class of drugs. Generic forms of… Continue reading FDA Allows Carcinogens In Popular Drugs
FDA Can’t Be Trusted on CBD
A Senate committee has approved language on CBD that will not protect consumer access to CBD supplements. Action Alert! Two weeks ago, we reported on efforts to preserve consumer access to therapeutic levels of CBD oil in supplements. The US Senate Appropriations Committee has approved report language for FY 2020 that falls far short of protecting… Continue reading FDA Can’t Be Trusted on CBD
Vitamin E Linked to Mysterious Vaping Sickness?
Not so fast. Action Alert! Recently, reports of illnesses and death linked to vaping have been all over the news. Although the exact cause of the lung illness is not known, the FDA is investigating the presence of vitamin E in many vaping products as a possible culprit. This may cause consumers to be concerned,… Continue reading Vitamin E Linked to Mysterious Vaping Sickness?
Protect CBD Access Before It’s Too Late
Unless the FDA makes an exception, consumers will lose access to affordable CBD oil. Action Alert! Over the last couple of years, ANH has been reporting on the many benefits of CBD oil, a non-psychoactive compound found in the hemp plant. Among other things, CBD oil is extremely helpful in managing pain. You might think… Continue reading Protect CBD Access Before It’s Too Late
Opioid Alternative CBD Under Threat
Take Action!
Save CBD Now!
Unless the FDA makes an exception, consumers will lose access to affordable CBD oil. Action Alert! Over the last couple of years, ANH has been reporting on the many benefits of CBD oil, a non-psychoactive compound found in the hemp plant. Among other things, CBD oil is extremely helpful in managing pain. You might think… Continue reading Save CBD Now!